Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis

Yao, WQ; Dong, HB; Qi, J; Zhang, Y; Shi, L

Zhang, Y (通讯作者)，Wuhan Opt Valley Vcanbio Cell Gene Technol Co Ltd, Wuhan, Hubei, Peoples R China.;Zhang, Y (通讯作者)，Wuhan Opt Valley Zhongyuan Pharmaceut Co Ltd, Wuhan, Hubei, Peoples R China.;Zhang, Y (通讯作者)，Hubei Engn Res Ctr Human Stem Cell Preparat Appli, Wuhan, Peoples R China.;Zhang, Y (通讯作者)，VCANBIO Cell Gene Engn Corp Ltd, 12 Meiyuan Rd, Tianjin, Peoples R China.;Zhang, Y (通讯作者)，State Ind Base Stem Cell Engn Prod, Tianjin, Peoples R China.;Shi, L (通讯作者)，Chinese Peoples Liberat Army Gen Hos

ECLINICALMEDICINE, 2022; 51 ():

Abstract

Background The present study aims to better understand the efficacy and safety of mesenchymal stromal cells (MSCs) in treating severe/critical patient......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索